FUL
ACHAT TOTAL: 1000 titres (~65830 USD) VENTE TOTALE: 9561 titres (~593332 USD)
- Insiders
- Rasmussen Trangsrud Teresa J, Weaver Nathan D.
- Total bought
- $65,830
- Total sold
- $593,332
- Last activity
- 2026-08-11
- Last synced
-
2026-08-25 17:08:49
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bullish signal Scored 2026-08-23
FUL presents a compelling event-driven setup with a strong M&A catalyst (unsolicited $1.1-1.2B bid for Building Adhesive Solutions, activist pressure from Engine Capital, and AMS acquisition approval), supported by…
The first sentence of the analysis written for FUL on 2026-08-23 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-11-29 | 2024-11-30 | 2023-12-02 | 2022-12-03 | 2021-11-27 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 31.7% | 30.1% | 29.2% | 25.7% | 25.8% | |
| Ebit Margin | 10.0% | 8.8% | 10.5% | 9.2% | 9.0% | |
| Ebitda Margin | 15.2% | 13.7% | 15.1% | 13.1% | 13.4% | |
| Operating Profit Margin | 11.5% | 10.3% | 10.8% | 8.6% | 7.8% | |
| Pretax Profit Margin | 6.3% | 5.2% | 6.8% | 6.9% | 6.8% | |
| Continuous Operations Profit Margin | 4.4% | 3.7% | 4.1% | 4.8% | 4.9% | |
| Net Profit Margin | 4.4% | 3.6% | 4.1% | 4.8% | 4.9% | |
| Bottom Line Profit Margin | 4.4% | 3.6% | 4.1% | 4.8% | 4.9% | |
| Current Ratio | 1.699 | 1.806 | 1.894 | 1.841 | 1.657 | |
| Quick Ratio | 1.064 | 1.156 | 1.256 | 1.144 | 1.049 | |
| Solvency Ratio | 0.104 | 0.098 | 0.103 | 0.115 | 0.114 | |
| Cash Ratio | 0.144 | 0.235 | 0.259 | 0.113 | 0.084 | |
| Price To Earnings Ratio | 20.964 | 32.443 | 28.798 | 23.837 | 24.230 | |
| Price To Earnings Growth Ratio | 1.212 | -2.887 | -1.386 | 2.272 | 0.861 | |
| Forward Price To Earnings Growth Ratio | 1.212 | -2.887 | -1.386 | 2.272 | 0.861 | |
| Price To Earnings Diluted Ratio | 21.193 | 33.430 | 29.687 | 24.641 | 24.882 | |
| Price To Earnings Diluted Growth Ratio | 1.083 | -2.986 | -1.444 | 2.524 | 0.963 | |
| Price To Book Ratio | 1.589 | 2.310 | 2.380 | 2.673 | 2.448 | |
| Price To Sales Ratio | 0.916 | 1.184 | 1.190 | 1.148 | 1.192 | |
| Price To Free Cash Flow Ratio | 26.252 | 25.881 | 16.113 | 34.011 | 33.340 | |
| Price To Operating Cash Flow Ratio | 12.077 | 13.966 | 11.040 | 16.779 | 18.322 | |
| Debt To Assets Ratio | 0.389 | 0.421 | 0.403 | 0.403 | 0.386 | |
| Debt To Equity Ratio | 1.007 | 1.135 | 1.084 | 1.118 | 1.033 | |
| Debt To Capital Ratio | 0.502 | 0.532 | 0.520 | 0.528 | 0.508 | |
| Long Term Debt To Capital Ratio | 0.502 | 0.524 | 0.511 | 0.519 | 0.499 | |
| Financial Leverage Ratio | 2.587 | 2.698 | 2.691 | 2.772 | 2.677 | |
| Working Capital Turnover Ratio | 6.317 | 5.952 | 5.789 | 6.956 | 6.731 | |
| Operating Cash Flow Ratio | 0.354 | 0.420 | 0.546 | 0.363 | 0.289 | |
| Operating Cash Flow Sales Ratio | 0.076 | 0.085 | 0.108 | 0.068 | 0.065 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.460 | 0.540 | 0.685 | 0.493 | 0.550 | |
| Debt Service Coverage Ratio | 3.449 | 3.247 | 3.189 | 3.433 | 3.639 | |
| Interest Coverage Ratio | 2.993 | 2.771 | 2.819 | 3.521 | 3.274 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 515.225 | 205.539 | 8.888 | 8.538 | |
| Operating Cash Flow Coverage Ratio | 0.131 | 0.146 | 0.199 | 0.143 | 0.129 | |
| Capital Expenditure Coverage Ratio | 1.852 | 2.172 | 3.176 | 1.974 | 2.220 | |
| Dividend Paid And Capex Coverage Ratio | 1.368 | 1.619 | 2.328 | 1.516 | 1.629 | |
| Dividend Payout Ratio | 0.331 | 0.365 | 0.299 | 0.217 | 0.216 | |
| Enterprise Value Multiple | 9.661 | 12.496 | 11.163 | 12.283 | 12.545 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 31.7% | ▲1.6% | ▲3.2% |
| Ebit Margin | 10.0% | ▲1.2% | ▲0.5% |
| Ebitda Margin | 15.2% | ▲1.4% | ▲1.1% |
| Operating Profit Margin | 11.5% | ▲1.1% | ▲1.7% |
| Pretax Profit Margin | 6.3% | ▲1.1% | ▼-0.1% |
| Continuous Operations Profit Margin | 4.4% | ▲0.7% | -0.0% |
| Net Profit Margin | 4.4% | ▲0.7% | -0.0% |
| Bottom Line Profit Margin | 4.4% | ▲0.7% | -0.0% |
| Current Ratio | 1.699 | ▼-0.107 | ▼-0.080 |
| Quick Ratio | 1.065 | ▼-0.092 | ▼-0.069 |
| Solvency Ratio | 0.104 | ▲0.006 | ▼-0.003 |
| Cash Ratio | 0.144 | ▼-0.091 | ▼-0.023 |
| Price To Earnings Ratio | 20.964 | ▼-11.479 | ▼-5.090 |
| Price To Earnings Growth Ratio | 1.212 | ▲4.099 | ▲1.198 |
| Forward Price To Earnings Growth Ratio | 1.212 | ▲4.099 | ▲1.198 |
| Price To Earnings Diluted Ratio | 21.193 | ▼-12.238 | ▼-5.574 |
| Price To Earnings Diluted Growth Ratio | 1.083 | ▲4.069 | ▲1.055 |
| Price To Book Ratio | 1.589 | ▼-0.721 | ▼-0.691 |
| Price To Sales Ratio | 0.916 | ▼-0.267 | ▼-0.210 |
| Price To Free Cash Flow Ratio | 26.252 | ▲0.371 | ▼-0.867 |
| Price To Operating Cash Flow Ratio | 12.077 | ▼-1.889 | ▼-2.360 |
| Debt To Assets Ratio | 0.389 | ▼-0.031 | ▼-0.011 |
| Debt To Equity Ratio | 1.007 | ▼-0.128 | ▼-0.068 |
| Debt To Capital Ratio | 0.502 | ▼-0.030 | ▼-0.016 |
| Long Term Debt To Capital Ratio | 0.502 | ▼-0.022 | ▼-0.009 |
| Financial Leverage Ratio | 2.587 | ▼-0.111 | ▼-0.098 |
| Working Capital Turnover Ratio | 6.317 | ▲0.365 | ▼-0.032 |
| Operating Cash Flow Ratio | 0.354 | ▼-0.066 | ▼-0.040 |
| Operating Cash Flow Sales Ratio | 0.076 | ▼-0.009 | ▼-0.004 |
| Free Cash Flow Operating Cash Flow Ratio | 0.460 | ▼-0.080 | ▼-0.086 |
| Debt Service Coverage Ratio | 3.449 | ▲0.203 | ▲0.058 |
| Interest Coverage Ratio | 2.993 | ▲0.222 | ▼-0.083 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | ▼-515.225 | ▼-147.638 |
| Operating Cash Flow Coverage Ratio | 0.131 | ▼-0.015 | ▼-0.019 |
| Capital Expenditure Coverage Ratio | 1.852 | ▼-0.320 | ▼-0.427 |
| Dividend Paid And Capex Coverage Ratio | 1.369 | ▼-0.250 | ▼-0.324 |
| Dividend Payout Ratio | 0.331 | ▼-0.035 | ▲0.045 |
| Enterprise Value Multiple | 9.661 | ▼-2.835 | ▼-1.969 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $3.18B | $4.22B | $4.18B | $4.30B | $3.91B | |
| Enterprise value | $5.09B | $6.13B | $5.90B | $6.02B | $5.50B | |
| EV / Sales | 1.47x | 1.72x | 1.68x | 1.61x | 1.68x | |
| EV / Op. cash flow | 19.32x | 20.27x | 15.59x | 23.48x | 25.77x | |
| EV / Free cash flow | 42.01x | 37.55x | 22.76x | 47.60x | 46.88x | |
| EV / EBITDA | 9.66x | 12.50x | 11.16x | 12.28x | 12.54x | |
| Net debt / EBITDA | 3.62x | 3.88x | 3.26x | 3.51x | 3.62x | |
| Current ratio | 1.70x | 1.81x | 1.89x | 1.84x | 1.66x | |
| Income quality | 1.73x | 2.32x | 2.61x | 1.42x | 1.32x | |
| Graham number | $48 | $42 | $44 | $48 | $46 | |
| Graham net-net | -$44 | -$41 | -$39 | -$38 | -$36 | |
| Tax burden | 69.3% | 69.7% | 60.8% | 70.0% | 71.9% | |
| Interest burden | 62.9% | 59.1% | 64.7% | 75.0% | 76.1% | |
| Working capital | $519.9M | $579.9M | $619.3M | $593.6M | $484.3M | |
| Invested capital | $3.94B | $3.83B | $3.71B | $3.42B | $3.17B | |
| Return on assets | 2.9% | 2.6% | 3.1% | 4.0% | 3.8% | |
| Operating ROA | 7.9% | 7.6% | 8.3% | 7.4% | 6.2% | |
| Return on tangible assets | 5.6% | 5.0% | 5.8% | 7.6% | 7.1% | |
| Return on equity | 7.6% | 7.1% | 8.3% | 11.2% | 10.1% | |
| Return on invested capital | 6.2% | 6.1% | 5.7% | 5.9% | 5.1% | |
| Return on capital employed | 9.0% | 8.8% | 9.4% | 8.6% | 7.2% | |
| Earnings yield | 4.8% | 3.1% | 3.5% | 4.2% | 4.1% | |
| Free cash flow yield | 3.8% | 3.9% | 6.2% | 2.9% | 3.0% | |
| Capex / Op. cash flow | 54.0% | 46.0% | 31.5% | 50.7% | 45.0% | |
| Capex / Depreciation | 79.8% | 79.7% | 74.5% | 88.4% | 67.1% | |
| Capex / Sales | 4.1% | 3.9% | 3.4% | 3.5% | 2.9% | |
| SG&A / Sales | 20.2% | 18.4% | 17.0% | 15.9% | 16.8% | |
| R&D / Sales | 0.0% | 1.4% | 1.4% | 1.2% | 1.2% | |
| Stock comp / Sales | 0.0% | 0.6% | 0.6% | 0.6% | 0.7% | |
| Intangibles / Total assets | 48.0% | 46.7% | 46.9% | 46.9% | 46.5% | |
| Days sales outstanding | 59d | 61d | 64d | 63d | 72d | |
| Days payables outstanding | 72d | 72d | 65d | 60d | 75d | |
| Operating cycle | 132d | 130d | 129d | 127d | 139d | |
| Cash conversion cycle | 60d | 58d | 65d | 67d | 64d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-14 Engine Capital Urges H.B. Fuller''s Board of Directors to Run a Market Check for the Building Adhesive Solutions Segment and the Entire Company NEW YORK--(BUSINESS WIRE)--Engine Capital LP (together with its affiliates, “Engine” or “we”), which owns approximately 2% of the outstanding shares of common stock of H.B. Fuller Company (NYSE: FUL) (“H.B. Fuller” or the “Company”), today released the following letter sent to the Company''s Board of Directors. *** August 14, 2026 H.B. Fuller Company 1200 Willow Lake Boulevard, P.O. Box 64683 St. Paul, Minnesota 55164-0683 Attention: The Board of Directors Members of the Board of Directors (the.
- 2026-08-13 H.B. Fuller Company''s Complexity Offers Potential H.B. Fuller Company remains a Buy candidate, with recent improvements in revenue and profitability despite prior underperformance and share price decline. FUL''s acquisition of Advanced Medical Solutions Group expands its total addressable market by $15 billion, but increases leverage and hinges on realizing $55 million in synergies. The company is evaluating an unsolicited $1.1–$1.2 billion cash offer for its Building Adhesives Solutions segment, which could reduce debt but permanently lower profitability.
- 2026-08-13 H.B. Fuller Announces AMS Shareholders Approve Proposed Acquisition ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (“H.B. Fuller”) (NYSE: FUL), the world''s largest pureplay adhesives company, today announced that shareholders of Advanced Medical Solutions Group plc (“AMS”) (LSE:AMS) approved H.B. Fuller''s proposed acquisition of AMS at specially convened meetings of AMS shareholders held on August 12, 2026. "We are pleased with this significant milestone," said Celeste Mastin, president and chief executive officer of H.B. Fuller. "AMS is an exceptional c.
- 2026-08-12 H.B. Fuller Confirms Receipt of Unsolicited Proposal for Building Adhesive Solutions Segment ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL), the world''s largest pureplay adhesives company, confirmed receipt of an unsolicited proposal today from Ancora Holdings Group to acquire its Building Adhesives Solutions (“BAS”) business for between $1.1 billion and $1.2 billion in cash. Although Ancora previously expressed a passing verbal interest in BAS, the letter received today, simultaneous to the news being made public, represents the firs.
- 2026-08-12 Ancora Comfortable With Its Offer for H.B. Fuller Unit Ancora Holdings Group is pushing to acquire H.B. Fuller Co.''s building adhesives unit for as much as $1.2 billion.
- 2026-08-12 Are Investors Undervaluing H. B. Fuller (FUL) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 2026-08-12 Ancora Holdings Group Submits Proposal to Acquire H.B. Fuller''s Building Adhesive Solutions Segment for $1.1 Billion to $1.2 Billion in Cash CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group LLC (together with its affiliates, “Ancora”), a meaningful shareholder of H.B. Fuller Company (NYSE: FUL) (“H.B. Fuller” or the “Company”), today released the below correspondence sent to the Company''s Board of Directors regarding Ancora''s proposal to acquire H.B. Fuller''s Building Adhesive Solutions (“BAS”) segment for between $1.1 billion and $1.2 billion in cash. The full text of the letter follows: August 12, 2026 H.B. Fuller Company Attn: T.
- 2026-08-07 FUL vs. NVZMY: Which Stock Is the Better Value Option? Investors interested in Chemical - Specialty stocks are likely familiar with H. B. Fuller (FUL) and Novozymes A/S (NVZMY).
- 2026-07-28 4 Chemical Specialty Stocks to Gain From Demand Rebound Improving demand in major end markets augurs well for The Zacks Chemicals Specialty industry. ESI, FUL, KWR and MTX lean on cost cuts and efficiency moves to offset persistent inflation pressures.
- 2026-07-27 Is H. B. Fuller (FUL) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.